Hemoglobin Current Events | Hemoglobin News | 4
|
|
|
Sort By:
Page Views | Date |
Acrylamide and health risks
Researcher Birgit Paulsson at Stockholm University have conducted follow-up studies of the leakage of acrylamides in connection with tunnel construction under the Halland Ridge in southwestern Sweden. The aim has primarily been to enhance the database for assessing health risks, primarily cancer risks, in connection with this exposure and in... view more... (2003-04-22)
Ways to avoid hazards of heart bypass under study
The heart-lung bypass machine that stills the heart while surgeons bypass an adult's clogged arteries or repair a baby's malformed heart can also trigger a potentially deadly inflammatory response. view more (2005-08-29)
Malaria parasite impairs key immune system cells
Plasmodium, the parasite responsible for malaria, impairs the ability of key cells of the immune system to trigger an efficient immune response. view more (2006-04-12)
Compound shows potential for slowing progression of ALS
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. view more (2009-10-20)
Colon cancer screening — Going 'Back To The Future'?
Colon cancer screening rates continue to lag behind those for breast and cervical cancer. view more (2007-02-20)
Quality improvement effort pays off in diabetes care
Spending money to improve diabetes care at federally qualified community health centers is a sound investment, according to one of the first studies to examine the clinical and economic impact of quality improvement on diabetes care. view more (2007-05-18)
Adult sickle cell drug proves effective in young children
A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder. view more (2005-09-20)
New malaria enzyme laid bare with help of computer calculations
Using only computers, a research team at Uppsala University in Sweden has managed to reveal both the structure and the function of a newly discovered enzyme from the most dangerous malaria parasite, Plasmodium falciparum. All that was needed was the amino acid sequence of the enzyme. The findings may represent a breakthrough for future... view more... (2004-12-07)
Stroke study reveals key target for improving treatment and suggests that Gleevec may help
For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke. view more (2008-06-23)
Heart has enough oxygen to survive hypothermia, CPR crucial
Researchers from Norway may have ruled out insufficient oxygen supply to the heart as the critical variable in whether a mammal's heart survives while in a hypothermic state. view more (2006-07-18)
Two tests better than one for diabetes control, Johns Hopkins expert tells doctors
In a strongly worded review published in the recent edition of The Journal of the American Medical Association (JAMA), the head of the Johns Hopkins Diabetes Center urges physicians and patients to better use the blood-testing tools at hand to manage the disease and prevent most of its dire impact on the heart, kidneys, nerves and vision. view more (2006-04-14)
Two genetic traits giving Africans malaria protection lose effectiveness when they occur together
Two genetic conditions-sickle cell trait and a mild version of the blood disorder known as thalassemia-that by themselves give millions of Africans natural protection against malaria. view more (2005-11-16)
Oral liquid hydroxyurea promising for long-term use in babies with sickle cell anemia
Treating babies who have sickle cell anemia (SCA) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital. view more (2005-06-16)
Antidepressant drug may prevent recurrence of depression in patients with diabetes
A team of researchers at Washington University School of Medicine in St. Louis found that an antidepressant medication may reduce the risk of recurrent depression and increase the length of time between depressive episodes in patients with diabetes. view more (2006-05-09)
Blood sugar control before surgery associated with fewer infections afterward
Patients with diabetes who have good control of blood glucose levels before having surgery may be less likely to have infections after their procedures. view more (2006-04-18)
Anemia affects body ... and maybe the mind
For older adults, anemia's trademark loss of oxygen-toting red blood cells has long been linked to fatigue, muscle weakness and other physical ailments. view more (2006-09-14)
Drug Combo Against AIDS-Related Infections Also Prevents Malaria
A drug combination used to prevent pneumonia and opportunistic bacterial infection in persons with HIV/AIDS has unexpectedly been found to be highly effective at preventing malaria. view more (2005-10-19)
Chemotherapy-induced anemia increases risk of local breast cancer recurrence
Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2008-04-01)
ABCB6 is key to production of heme in hemoglobin
Investigators at St. Jude Children's Research Hospital have discovered that a protein called ABCB6 plays a central role in production of a molecule that is key to the ability of red blood cells to carry oxygen, of liver cells to break down toxins, and of cells to extract energy from nutrients. view more (2006-09-29)
Network model predicts risk of death in sickle cell disease
Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have developed a method to estimate sickle cell disease severity and predict the risk of death in people with this disease. view more (2007-07-12)
|
|
|
|
Sort By:
Page Views | Date |
|
